ASPI ASP Isotopes Inc.

ASPI financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1921865 Exchange: Nasdaq SIC: 2890 (Miscellaneous Chemical Products) Latest filing: 10-Q filed Aug 14, 2026 Data checked: Oct 21, 2026
Showing 3 of 4 annual and 0 of 15 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
<br>Emerging growth company
Entity Type
Operating
Public Float
$399.80M (Jun 2025)
Industry (SIC)
2890 Miscellaneous Chemical Products
Incorporated
DE
Fiscal Year End
December (1231)
Phone
202-756-2245
EIN
872618235
Headquarters
DALLAS, TX, 75201
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$30.85M
Net Income
$-117.34M
Total Assets
$572.05M
Total Equity
$274.79M
Total Debt
$59.77M
Free Cash Flow
$-83.58M
Ratios
Gross Margin
18.3%
Operating Margin
-321.1%
Net Margin
-380.3%
Return on Equity
-42.7%
Return on Assets
-20.5%
Current Ratio
3.87x
Debt / Equity
0.22x
FCF / Assets
-14.6%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for ASP Isotopes Inc. combined $23.85M of revenue with net loss of $159.84M and an operating cash outflow of $37.78M. At $23.85M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 475.5% above fiscal 2024 revenue of $4.14M, marking a year-over-year increase. Diluted earnings per share were -$2.11, translating the period’s attributable earnings into the amount reported for each diluted share. Total assets stood at $498.02M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. The revenue-to-assets relationship was 0.05x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $3.40M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 14.3%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced a $59.91M operating loss before non-operating and tax effects. The operating loss equaled 251.2% of revenue, showing the scale of the operating deficit relative to sales. After all below-operating-line items, the company recorded a net loss of $159.84M for the fiscal year. Net margin was -670.2%, reflecting a loss equal to 670.2% of reported revenue. Before income taxes, the company recorded a loss of $159.56M, bridging the operating result to the final net loss. The pretax loss equaled 669.0% of revenue, measuring the pre-tax deficit against sales. The company recognized $282.00K of income tax for the period, completing the transition from pretax income to net income. Relative to period-end equity, the net loss represented 60.8%. Relative to total assets, the net loss represented 32.1%. The net loss widened to $159.84M from $32.42M in fiscal 2024.

Liquidity and Capital Structure

At period end, the $498.02M asset base was financed through $235.12M of liabilities and $262.90M of equity. At period end, current assets of $399.92M compared with current liabilities of $32.70M, defining the company’s short-term resource position. Current assets covered current liabilities by 12.23x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $285.60M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 873.5% of current liabilities, showing how much near-term coverage came from cash alone. The company carried $14.36M of total debt at period end, which frames its leverage and debt-service burden. The debt-to-equity relationship was 0.05x, showing how much debt the company carried for each unit of book equity. Relative to total assets, debt measured 2.9%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 47.2%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 57.3% of total assets, showing the liquid cash component within the company’s broader resource base. Total assets were 427.9% higher than fiscal 2024 assets of $94.35M, measuring the company’s own balance-sheet change. Book equity was 413.8% higher than fiscal 2024 equity of $51.17M, showing how shareholder capital changed year over year. Compared with $61.89M in fiscal 2024, the current cash balance moved 361.5% and finished higher.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $37.78M, rather than cash generation from operations. Capital spending of $9.65M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. The company recorded a $47.43M cash deficit after capital spending for the period. The free-cash-flow deficit equaled 198.9% of revenue, showing the post-investment cash shortfall relative to sales. Relative to total assets, the post-investment cash deficit measured 9.5%.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for ASP Isotopes Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $23.85M $4.14M $433.03K
Cost of Revenue $20.44M $2.55M $294.06K
Gross Profit $3.41M $1.60M $138.97K
OPERATING EXPENSES
R&D Expense $12.36M $3.14M $764.58K
SG&A Expense $48.24M $24.81M $15.42M
Other Operating Expenses (derived) $2.72M $0 $0
Operating Income $-59.91M $-26.35M $-16.04M
NON-OPERATING INCOME / EXPENSE
Interest Expense $9.38K $17.87K $118.55K
Interest Income $6.79M $1.24M $9.07K
Other Income/Expense $-99.65M $-5.96M $-258.26K
Pretax Income $-159.56M $-32.31M $-16.30M
Income Tax $282.00K $111.00K $-6.13K
Net Income $-159.84M $-32.42M $-16.29M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-2.11 $-0.63 $-0.49
Diluted Shares 83.01M 55.67M 33.07M
EBITDA $-58.00M $-25.88M $-16.00M
Depreciation & Amortization $1.91M $471.00K $37.43K
Balance Sheet
ASSETS
Cash & Equivalents $285.60M $61.89M $7.91M
Short-term Investments $47.75M $0 -
Accounts Receivable $17.88M $707.00K $216.50K
Inventory $1.10M $66.00K $0
Other Current Assets $13.84M $3.05M $1.66M
Current Assets $399.92M $65.74M $10.51M
PP&E (Net) $33.45M $22.35M $10.71M
Goodwill $8.57M $3.17M $3.27M
Intangible Assets $1.48M - -
Other Noncurrent Assets $5.36M $1.93M $1.79M
Noncurrent Assets $98.10M $28.60M $17.03M
Total Assets $498.02M $94.35M $27.54M
LIABILITIES
Accounts Payable $5.76M $1.02M $1.11M
Short-term Debt $12.89M $939.00K -
Other Current Liabilities $2.04M $1.26M $1.50M
Current Liabilities $32.70M $7.06M $5.67M
Long-term Debt $1.47M $1.44M -
Other Noncurrent Liabilities (derived) $200.96M $0 $1.65M
Noncurrent Liabilities $202.43M $36.12M $3.04M
Total Liabilities $235.12M $43.18M $8.71M
EQUITY
Common Stock $1.12M $721.00K $489.23K
Additional Paid-in Capital $431.76M $105.52M $40.57M
Retained Earnings $-231.27M $-56.17M $-23.84M
Accumulated OCI $2.54M $-2.16M $-920.98K
Total Equity $262.90M $51.17M $18.83M
Total Liabilities & Equity $498.02M $94.35M $27.54M
SUPPLEMENTAL
Total Debt $14.36M $2.38M -
Shares Outstanding 111.68M 72.07M 48.92M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $-37.78M $-16.70M $-5.41M
Capital Expenditures $9.65M $9.68M $2.33M
Cash from Investing $-110.79M $-11.37M $-2.45M
Cash from Financing $371.60M $82.53M $13.39M
Free Cash Flow $-47.43M $-26.37M $-7.74M
Beginning Cash (CFS) $61.89M $7.91M $2.39M
Net Change in Cash $223.03M $54.47M $5.52M
Effect of FX on Cash $647.00K $-484.00K $-867
Calculated Ending Cash $285.56M $61.89M $7.91M
Cash per BS $285.60M $61.89M $7.91M
Cash scope difference (CFS − BS) $-37.00K - -
Cash per CFS $285.56M $61.89M $7.91M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is ASP Isotopes Inc.'s annual revenue?

ASP Isotopes Inc. reported $30.85M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is ASP Isotopes Inc. profitable?

No. ASP Isotopes Inc. reported $-117.34M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

What is ASP Isotopes Inc.'s debt level?

ASP Isotopes Inc. carries $59.77M in total debt as of trailing twelve months. Total shareholders' equity stands at $274.79M.

Does ASP Isotopes Inc. generate free cash flow?

No. Free cash flow was $-83.58M for trailing twelve months. Operating cash flow was $-67.80M.